Feedback

Browsing by S

Use an asterisk (*) for partial word searches (e.g. pemph*)

146 results found.

1.
2.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

3.
Ordering Recommendation:  

Useful as a biomarker of various CNS pathologies and as a tumor marker for malignant melanoma.

4.
Ordering Recommendation:  

Test may be useful as a biomarker of various CNS pathologies.

5.
Ordering Recommendation:  

May be useful for the diagnosis of Crohn disease. Test by itself is not diagnostic and should be used in conjunction with other parameters to confirm disease. Inflammatory Bowel Disease Differentiation Panel (2013270) is the preferred test.

6.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

7.
Ordering Recommendation:  

Aid in assessment of the etiology of anion gap acidosis.

8.
Ordering Recommendation:  

May be used to determine past exposure to S. typhii (eg, infection or vaccination) and S. paratyphi. This test cannot be used to confirm acute salmonellosis. If systemic symptoms of acute salmonellosis are present, the preferred tests are Stool Culture and E. coli Shiga-like Toxin by EIA (0060134) and Blood Culture (0060102) if typhoid fever is suspected.

9.
Ordering Recommendation:  

Aid in the diagnosis of schistosomiasis. Positive results in patients from endemic areas may not represent active infection.

10.
Ordering Recommendation:  

Useful for diagnosis of systemic scleroderma/sclerosis (SSc). Negative results do not rule out SSc. Preferred test is Systemic Scleroderma Comprehensive Panel (2013325).

11.
12.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

13.
14.
Ordering Recommendation:  

Non-specific test used to detect inflammation associated with infections, cancers, and autoimmune diseases.

15.
Ordering Recommendation:  

May be useful in the assessment of tissue stores. For routine asessment of selenium deficiency or toxicity, Selenium, Urine (0025067) is preferred.

16.
Ordering Recommendation:  

May be useful in the assessment of recent intake. For the assessment of deficiency or toxicity, Selenium, Urine (0025067) is preferred.

17.
Ordering Recommendation:  

Urine is the preferred specimen type for the assessment of selenium toxicity and deficiency. For the assessment of recent intake, Selenium, Serum or Plasma is available (0025023).

18.
19.
20.
Ordering Recommendation:  

Screen for colorectal cancer. This test is NOT recommended for pregnant women as it has been associated with false positives in these individuals.

21.
Ordering Recommendation:  

• When used in conjunction with other autoantibody tests (ANCA, MPO), may assist in differentiating suspected Wegener granulomatosis (WG) from other vasculitides.
• May be useful when monitoring patients with PR-3 antibodies.
• Panel tests are available.
 ○ For the workup of suspected vasculitis, refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR-3) Reflex to ANCA Titer (2006480).
 ○ For patients with a history of vasculitis, refer to the ANCA Reflex to Titer and MPO/PR-3 Antibodies (2002068).

22.
Ordering Recommendation:  

Gold standard test for diagnosis of HIT.

23.
Ordering Recommendation:  

Preferred serotonin test when diagnosing carcinoid tumors is whole blood (0080395).

24.
Ordering Recommendation:  

Use to diagnose and monitor carcinoid tumors. Preferred serotonin test since most of the blood serotonin resides in the platelets.

25.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

26.
Ordering Recommendation:  

Preferred test for individuals with
• Clinical phenotype of SCID, Omenn syndrome or other combined immunodeficiency disorders
• Abnormal newborn screen T-cell receptor excision circles (TREC) test result suggestive of SCID

27.
28.
Ordering Recommendation:  

Preferred test for detecting Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in variety of specimens.

29.
Ordering Recommendation:  

Aid in identification of mycosis fungoides and the Sezary syndrome.

30.
Ordering Recommendation:  

Refer to Additional Technical Information document.

31.
32.
Ordering Recommendation:  

Refer to Additional Technical Information document.

33.
34.
35.
36.
37.
38.
39.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

40.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

41.
Ordering Recommendation:  

Preferred test for individuals with a previously identified familial deletion/duplication. Secondary diagnostic test if sequencing does not detect the causative pathogenic variant. This is a second-tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering.

42.
Ordering Recommendation:  

Preferred test for individuals with an undetermined skeletal dysplasia.

43.
Ordering Recommendation:  

Prenatal diagnosis for suspected fetal skeletal dysplasia.

44.
Ordering Recommendation:  

Acceptable test for individuals with an undetermined skeletal dysplasia.

45.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

46.
Ordering Recommendation:  

Confirmatory test for systemic lupus erythematosus (SLE) based on ANA results.

47.
Ordering Recommendation:  

Confirm a clinical or biochemical diagnosis of Smith-Lemli-Opitz syndrome(SLOS) or carrier screening for SLOS.

48.
Ordering Recommendation:  

Diagnostic fetal testing for pregnancies suspected to be affected with Smith-Lemli-Opitz syndrome (SLOS).

49.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

50.
Ordering Recommendation:  

May be helpful in evaluating for autoimmune liver disease. For a more comprehensive reflex panel, refer to 2007210.

51.
52.
Ordering Recommendation:  

Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.

53.
54.
55.
Ordering Recommendation:  

Aids in therapeutic decisions for solid tumor cancers. Does not detect translocations.

56.
Ordering Recommendation:  

Not recommended; order D-dimer test (0030057) instead.

57.
58.
Ordering Recommendation:  

MESOMARK is FDA approved for use as a Humanitarian Use Device. IRB registration and certification is required prior to ordering. Follow procedures listed below in specimen requirements.

59.
60.
61.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

62.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

63.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

64.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

65.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

66.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

67.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

68.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

69.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

70.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

71.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

72.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

73.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

74.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

75.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

76.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

77.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

78.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

79.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

80.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

81.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

82.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

83.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

84.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

85.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

86.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

87.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

88.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

89.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

90.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

91.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

92.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

93.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

94.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

95.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

96.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

97.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

98.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

99.
Ordering Recommendation:  

Refer to the listing of histochemical stains at www.aruplab.com/ap/tests/histochemical.

100.
101.
102.
Ordering Recommendation:  

Prenatal or preconception carrier screening for spinal muscular atrophy (SMA). Carrier testing for parents of a child with a deletion of the SMN1 gene or other family history of SMA. Not recommended for SMA diagnostic testing.

103.
Ordering Recommendation:  

• Diagnostic testing to confirm a suspected diagnosis of spinal muscular atrophy (SMA).
• Prenatal or preconception carrier screening for SMA in the general population.
• Carrier screening for reproductive partner of known SMA carrier.
• Carrier screening for parents of a child with a deletion of the SMN1 gene or other family history of SMA.

104.
Ordering Recommendation:  

Prenatal diagnostic testing for spinal muscular atrophy (SMA) when both parents carry a deletion of SMN1 or have a previous child with SMA caused by a deletion of SMN1.

105.
106.
Ordering Recommendation:  

Useful as a tumor marker for squamous cell carcinomas of the head and neck, uterine cervix, lung, vulva, and esophagus.

107.
Ordering Recommendation:  

Molecular diagnosis of synovial sarcoma.

108.
Ordering Recommendation:  

Molecular diagnosis of synovial sarcoma.

109.
Ordering Recommendation:  

Order as secondary screen based on results of ANA test or if ANA IFA is negative and Sjögren syndrome, systemic lupus erythematosus (SLE), or myositis is strongly suspected.

110.
Ordering Recommendation:  

Recommended for the differential diagnosis of SLE and Sjogren syndrome. Preferred panel contains SSA 52, SSA 60, and SSB; refer to 0050791.

111.
112.
Ordering Recommendation:  

B-Type Natriuretic Peptide (0030191) or proBrain Natriuretic Peptide, NT (0050083) are preferred tests for diagnosis, prognosis, and management of acute and chronic heart failure. ST2 aids in prognostication in patients with acute and chronic heart failure.

113.
114.
Ordering Recommendation:  

Identify Staphylococcus aureus colonization.

115.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

116.
Ordering Recommendation:  

Identify individuals at increased risk for statin-related muscle toxicity.

117.
Ordering Recommendation:  

Preferred test for suspected bacterial diarrhea evaluation. Testing includes cultures for Salmonella, Shigella, Campylobacter, E. coli 0157, and EIA for Shiga-like toxin from E. coli. For C. difficile testing, refer to Clostridium difficile toxin B gene (tcdB) by PCR (2002838).

118.
Ordering Recommendation:  

Identify presence of Campylobacter species in stool as potential cause of diarrhea with appropriate exposure history or risk factors.

119.
Ordering Recommendation:  

Diagnose Vibrio-associated diarrhea in patients with appropriate exposure history or risk factors.

120.
Ordering Recommendation:  

Diagnose Yersinia-associated diarrhea in patients with appropriate exposure history or risk factors.

121.
Ordering Recommendation:  

Gold standard for confirming group A streptococcal infection. Order when rapid testing is negative and suspicion of streptococcus is moderately high.

122.
123.
Ordering Recommendation:  

Determine genital and rectal Group B Streptococcus in pregnant women.

124.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

125.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

126.
Ordering Recommendation:  

Evaluate the ability of a patient to produce antibody to pure polysaccharide vaccines (Pneumovax) or protein conjugated vaccines (Prevnar).

127.
Ordering Recommendation:  

Aid in the diagnosis of pneumococcal meningitis.

128.
Ordering Recommendation:  

Aid in the diagnosis of pneumococcal pneumonia.

129.
130.
Ordering Recommendation:  

Outdated test. Recommend DNase-B antibody and/or Streptolysin O antibody tests.

131.
Ordering Recommendation:  

Confirm a prior infection with group A Streptococcus in patients suspected of having a nonsuppurative complication such as acute glomerulonephritis (AGN) or acute rheumatic fever (ARF). DNase-B (0050220) and streptolysin O (ASO) (0050095) antibody tests are generally ordered concurrently.

132.
Ordering Recommendation:  

Recommended for differential evaluation of neuromuscular junction diseases including myasthenia gravis (MG).

133.
Ordering Recommendation:  

Aid in the diagnosis of strongyloides. Positive results in patients from endemic areas may not represent active infection.

134.
135.
136.
Ordering Recommendation:  

Use to monitor patients with tyrosinemia type 1 or for quantifying succinylacetone at diagnosis. To rule out or diagnose tyrosinemia type 1, refer to Organic Acids, Urine (0098389) and Amino Acids Quantitative by LC-MS/MS, Plasma (2009389).

137.
Ordering Recommendation:  

Measurement of urinary sulfate excretion is used in calculi risk assessment.

138.
Ordering Recommendation:  

Non-panel testing for autoimmune neuropathies. Test by itself is not diagnostic and should be used in conjunction with other clinical parameters to confirm disease.

139.
140.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

141.
Ordering Recommendation:  

Test may be useful in evaluating if etiology of hypoglycemia is from exposure to sulfonylurea hypoglycemic drugs. However, serum or plasma is the preferred specimen (refer to Hypoglycemia Panel, Sulfonylureas Qualitative, Serum or Plasma (2010292)).

142.
Ordering Recommendation:  

Use  for kidney stone risk assessment and monitoring; includes interpretation of data. Panel includes calcium, chloride, citric acid, creatinine, magnesium, oxalate, pH, phosphorous, potassium, sodium, sulfate, and uric acid.

143.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

144.
Ordering Recommendation:  

May be useful in the assessment of exposure to synthetic cannabinoids up to several days post-exposure.

145.
Ordering Recommendation:  

Comprehensive evaluation of systemic scleroderma/sclerosis (SSc). Indicated when suspicion for SSc is high and patient presents with features of overlap disease.

146.
Ordering Recommendation:  

Indicated for patients with distinct features of systemic scleroderma (SSc). Negative results do not rule out SSc. If negative and suspicion for SSc is strong, consider testing for U3 RNP (fibrillarin), PM/Scl-100, U1RNP, Th/Tho, or other connective tissue disease autoantibodies based on patient’s clinical presentation.